Dr Jonathan Faro of the UTHSC at Houston presented two posters at the IDSOG meeting in Albuquerque showing the results of tests with NanoLogix BNF and new Multiwell N-Assay diagnostics. The N-Assay delivered 30 minute results for detection and identification of Group B Streptococcus (GBS) while the BNF provided detection, identification, and determination of sensitivity to clindamycin antibiotic in 6 - 6.5 hours. Both tests are significantly faster than the standard tests in use, which take 48-72 hours for the same results. The significance of the results and impact upon screening for GBS in pregnancies, and potentially in the elderly and immuno-compromised patients of all ages, is tremendous.

Now that NNLX has the patents it would be great if they could land a major partner that has the RESOURCES to market and sell the products. Then it's off to the races.